[Clinical course study in thrombophilia].
The course of the disease in a 46 yr old female patient was characterised by an unusual frequency of thromboembolic complications. Thrombogenic factors were diathesis to cystine stones since adolescence, intake of oral contraceptives for 5 years, immune complex disease, liver cell adenoma, open foramen ovale. Differential therapeutic measures for treatment of thromboembolism were applied. Changes in clotting variables and pathogenetic aspects are discussed.
D020152:Antithrombin III Deficiency; D001780:Blood Coagulation Tests; D006528:Carcinoma, Hepatocellular / Q000097:blood; D002715:Chlormadinone Acetate / Q000009:adverse effects; D003277:Contraceptives, Oral, Combined / Q000009:adverse effects; D003553:Cystine / Q000097:blood; D003554:Cystinosis / Q000097:blood; D004338:Drug Combinations; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007105:Immune Complex Diseases / Q000097:blood; D007669:Kidney Calculi / Q000097:blood; D008113:Liver Neoplasms / Q000097:blood; D008656:Mestranol / Q000009:adverse effects; D008875:Middle Aged; D009640:Norethindrone / Q000009:adverse effects; D011655:Pulmonary Embolism / Q000097:blood; D013923:Thromboembolism / Q000097:blood* / Q000139:chemically induced; D013924:Thrombophlebitis / Q000097:blood
D003277:Contraceptives, Oral, Combined; D004338:Drug Combinations; D002715:Chlormadinone Acetate; D003553:Cystine; C010260:Non-Ovlon; C002785:Ovosiston; D008656:Mestranol; D009640:Norethindrone
Klinische Verlaufsbeobachtung zur Thrombophilie.